Corvus Pharmaceuticals Inc buy Barclays PLC
Start price
20.01.26
/
50%
€18.30
Target price
20.01.27
-
Performance (%)
-2.84%
Price
20.01.26
€13.28
Summary
This prediction is currently active. With a performance of -2.84%, the BUY prediction by Barclays_PLC is trending in the wrong direction. This prediction currently runs until 20.01.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Corvus Pharmaceuticals Inc | -2.84% |
| iShares Core DAX® | -3.141% |
| iShares Nasdaq 100 | -3.518% |
| iShares Nikkei 225® | -3.396% |
| iShares S&P 500 | -2.943% |
Comments by Barclays_PLC for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals (NASDAQ:CRVS) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Ratings data for CRVS provided by MarketBeat